Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530016) titled 'Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma' on April 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical College

Condition: Melasma Treatment of Stable Melasma Tranexamic Acid Laurocapram

Intervention: Combination Product: Ligustrazine - tranexamic acid - aloe polysaccharide composite gel

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollme...